Industry Goes On Offensive Against Prescription Pseudoephedrine Trend
This article was originally published in The Pink Sheet Daily
Drug firms hope to dissuade states from moving drugs that contain methamphetamine precursors to prescription status by funding electronic systems to track nonprescription sales of the products.
You may also be interested in...
Legislation drafted by Sen. Ron Wyden would require prescriptions for all products containing the methamphetamine precursor pseudoephedrine
Some drugstore chains are tracking sales of methamphetamine precursors with their own electronic systems, but Sen. Chuck Grassley says a national approach may be needed to effectively prevent consumers from evading limits on retail purchases of the products
Adequate funding for electronic databases to track retail sales of pseudoephedrine products may be needed to convince law enforcement officials in states besieged by manufacturing of methamphetamine that current PSE sales restrictions are sufficient